SE9602262D0 - New use of cystine derivatives - Google Patents

New use of cystine derivatives

Info

Publication number
SE9602262D0
SE9602262D0 SE9602262A SE9602262A SE9602262D0 SE 9602262 D0 SE9602262 D0 SE 9602262D0 SE 9602262 A SE9602262 A SE 9602262A SE 9602262 A SE9602262 A SE 9602262A SE 9602262 D0 SE9602262 D0 SE 9602262D0
Authority
SE
Sweden
Prior art keywords
new use
cystine derivatives
cystine
derivatives
infections
Prior art date
Application number
SE9602262A
Other languages
Swedish (sv)
Inventor
Haakan Bergstrand
Jan Rollof
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9602262A priority Critical patent/SE9602262D0/en
Publication of SE9602262D0 publication Critical patent/SE9602262D0/en
Priority to ARP970102236A priority patent/AR007294A1/en
Priority to ZA9704679A priority patent/ZA974679B/en
Priority to IDP971863A priority patent/ID17383A/en
Priority to PCT/SE1997/000990 priority patent/WO1997046229A1/en
Priority to AU31141/97A priority patent/AU3114197A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The use of a derivative of cystine, or physiologically acceptable salts thereof, for the preparation of a medicament for the treatment of chronic hepatitis B and/or C infections.
SE9602262A 1996-06-06 1996-06-06 New use of cystine derivatives SE9602262D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9602262A SE9602262D0 (en) 1996-06-06 1996-06-06 New use of cystine derivatives
ARP970102236A AR007294A1 (en) 1996-06-06 1997-05-26 NEW USE OF CYSTINE DERIVATIVES
ZA9704679A ZA974679B (en) 1996-06-06 1997-05-28 New use of derivatives of cystine.
IDP971863A ID17383A (en) 1996-06-06 1997-06-02 LATEST USE OF SISTINA DOWN
PCT/SE1997/000990 WO1997046229A1 (en) 1996-06-06 1997-06-05 New use of derivatives of cystine
AU31141/97A AU3114197A (en) 1996-06-06 1997-06-05 New use of derivatives of cystine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602262A SE9602262D0 (en) 1996-06-06 1996-06-06 New use of cystine derivatives

Publications (1)

Publication Number Publication Date
SE9602262D0 true SE9602262D0 (en) 1996-06-06

Family

ID=20402927

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9602262A SE9602262D0 (en) 1996-06-06 1996-06-06 New use of cystine derivatives

Country Status (6)

Country Link
AR (1) AR007294A1 (en)
AU (1) AU3114197A (en)
ID (1) ID17383A (en)
SE (1) SE9602262D0 (en)
WO (1) WO1997046229A1 (en)
ZA (1) ZA974679B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3988014B2 (en) * 2000-02-02 2007-10-10 味の素株式会社 Antiviral agent
US7829709B1 (en) 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
WO2009100431A1 (en) * 2008-02-07 2009-08-13 Marquette University Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
JP6814312B1 (en) * 2020-02-05 2021-01-13 株式会社タイショーテクノス How to impart antiviral properties to antiviral agents and articles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981003330A1 (en) * 1980-05-13 1981-11-26 Mitsubishi Chem Ind Cysteine derivative and production thereof
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Pharmaceutical compositions comprising cystine derivatives
SE9103572D0 (en) * 1991-11-29 1991-11-29 Astra Ab ORGANIC SALTS OF N, N'-DIACETYL CYSTINE

Also Published As

Publication number Publication date
AR007294A1 (en) 1999-10-27
AU3114197A (en) 1998-01-05
WO1997046229A1 (en) 1997-12-11
ID17383A (en) 1997-12-24
ZA974679B (en) 1997-12-08

Similar Documents

Publication Publication Date Title
EA200101156A1 (en) DRUG COMPOSITIONS OF A NEW TYPE ON THE BASIS OF POSSESSING HOLYNTHERGIC ACTION OF COMPOUNDS AND β-MIMETIC
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
SE8804629D0 (en) NEW THERAPEUTICALLY ACTIVE COMPOUNDS
ES2058892T3 (en) USE OF OMEPRAZOLE AS ANTIMICROBIAL AGENT.
BR0109703A (en) Piperazine Derivatives
BR0111195A (en) Use of b-1,2'-deoxy-nucleosides in the treatment of hepatitis delta virus infection
DE69206378D1 (en) Patient tables.
DK0959888T3 (en) Use of the clioquinol chelating agent in the preparation of a pharmaceutical composition for the treatment of Alzheimer's disease
NO924775D0 (en) SUBSTITUTED BENZIMIDAZOLES, PROCEDURES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE
CY1107465T1 (en) MELAGATRANI FOR THERAPEUTIC INFECTION
DK0998287T3 (en) Use of levobupivacaine
DK261490D0 (en) NEW PHARMACEUTICAL COMPOUND
DE59009354D1 (en) Dental patient chair.
DE59204364D1 (en) Dental patient chair.
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
DE60128100D1 (en) ANALGICAL DRUG
DK561089D0 (en) USE OF LACTAMIMIDES FOR THE PREPARATION OF MEDICINAL PRODUCTS
DK0781560T3 (en) Use of immunoglobulin preparations for the manufacture of a medicament for oral administration for treatment and prevention
EE05241B1 (en) Use of the α-halogenoacryl derivative of distamycin
ITMI911470A0 (en) N-(5-THIOXO-L-PROLYL)-L-CYSTEINE AND ITS DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE
SE9602262D0 (en) New use of cystine derivatives
ATE122562T1 (en) PENCICLOVIR DERIVATIVES FOR THE TREATMENT OF HEPATITIS B INFECTIONS.
NO20032006D0 (en) Use of melagatran for the manufacture of a medicament for the treatment of ischemic disorders
DE68906245D1 (en) THERAPEUTIC AGENT AGAINST AIDS.
DK0458587T3 (en) Treatment of ocular hypertension with a synergistic combination for ophthalmic use